RAD51 potentiates synergistic effects of chemotherapy with PCI-24781 and cis-diamminedichloroplatinum on gastric cancer. - Wikidata - awgldk - TriplyDB

RAD51 potentiates synergistic effects of chemotherapy with PCI-24781 and cis-diamminedichloroplatinum on gastric cancer.

RAD51 potentiates synergistic effects of chemotherapy with PCI-24781 and cis-diamminedichloroplatinum on gastric cancer.

http://www.wikidata.org/entity/Q34008663

about

The histone deacetylase inhibitor PCI-24781 as a putative radiosensitizer in pediatric glioblastoma cell lines.

P2860

Q36810416-25262223-1CBE-446E-BC36-C811461CFE56

P2860

RAD51 potentiates synergistic effects of chemotherapy with PCI-24781 and cis-diamminedichloroplatinum on gastric cancer.

http://www.wikidata.org/entity/Q34008663

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

RAD51 potentiates synergistic ...... oroplatinum on gastric cancer.

@ast

RAD51 potentiates synergistic ...... oroplatinum on gastric cancer.

@en

RAD51 potentiates synergistic ...... oroplatinum on gastric cancer.

@nl

type

label

RAD51 potentiates synergistic ...... oroplatinum on gastric cancer.

@ast

RAD51 potentiates synergistic ...... oroplatinum on gastric cancer.

@en

RAD51 potentiates synergistic ...... oroplatinum on gastric cancer.

@nl

prefLabel

RAD51 potentiates synergistic ...... oroplatinum on gastric cancer.

@ast

RAD51 potentiates synergistic ...... oroplatinum on gastric cancer.

@en

RAD51 potentiates synergistic ...... oroplatinum on gastric cancer.

@nl

P1433

Q34008663-25F50309-9870-4CB0-8C1C-CF2C7ED47C61

P1476

Q34008663-CF5E9365-85DA-4FEE-A804-A9D7AE1D7E63

P2093

Q34008663-05DB8473-C9FB-4DB4-8089-DF8F3D1BF5AF

Q34008663-11CDBC15-CE82-425E-BC03-030D84D32EE4

Q34008663-3306D432-787D-4E94-ABDD-D1052E061E34

Q34008663-499D0610-3AF2-4545-8982-A43681291DED

Q34008663-541EF735-FC19-48AB-B634-1C539FA34923

Q34008663-5B6063B8-1915-40CA-86AA-9F043D2CF76D

Q34008663-7D0FBE8B-C725-4581-870E-D741CC5A8CC5

Q34008663-95A7FBF5-EFBE-42E1-8B4E-49B0878FD578

Q34008663-E592B3D2-46F8-4334-9366-FF3FC06DC62B

P2860

Q34008663-0125D69A-874F-4ABD-8ABF-6E56808CB836

Q34008663-060858CD-D1E1-4719-BB22-11E8112F35DD

Q34008663-1224550B-4516-4207-9E65-7A507A1B0759

Q34008663-1BC25DF3-7D30-4A91-9E4E-44FEFE3A52A1

Q34008663-1D5148F7-3861-4447-B28B-DC51BCD88518

Q34008663-1E0C7AAB-32A2-499B-BDE4-84EC8DDA0AAE

Q34008663-473FF2EA-6A7E-48F0-A526-903CC98C803D

Q34008663-4946A111-A354-442F-BB91-C54F81A24006

Q34008663-539B21A6-6FD2-4AB2-BFA4-245CEEB4C50C

Q34008663-5DA0456F-2F35-4945-9768-DC81ED1749CE

P304

Q34008663-92F37733-6B93-45BE-A4E6-3CC643D66B63

P31

Q34008663-2AB0B25C-933B-41D3-A6EE-31CC769CF298

P356

Q34008663-646E7EE1-D7E2-467B-9CDB-107FBFB592C3

P407

Q34008663-CBC90485-82F2-405B-9DC6-545CF6D36070

P433

Q34008663-E79FAF0F-13CA-45D3-AB60-9C1E81088B39

P478

Q34008663-2FC5D0D2-5D8B-49C5-A60D-1E23CD44B5A4

P50

Q34008663-4D333BC6-9A9F-4FF6-A457-B90F69C002FD

P577

Q34008663-B2DB22C4-6F3C-45B8-A9F0-C9B3397EE7BB

P5875

Q34008663-6B1DCE41-3BD0-441E-8B2B-64F0E915A2A9

P698

Q34008663-48D009A3-A1B2-4218-A8E5-96D5148D8FF8

P932

Q34008663-888D7434-FDED-4CB8-AFA8-ED3B139C6626

P356

WJG.V20.I29.10094

P1433

World Journal of Gastroenterology

P1476

RAD51 potentiates synergistic ...... loroplatinum on gastric cancer

@en

P2093

Chang-Hua Zhang

http://www.w3.org/2001/XMLSchema#string

Li-Ya Lu

http://www.w3.org/2001/XMLSchema#string

Shi-Rong Cai

http://www.w3.org/2001/XMLSchema#string

Wei-Jian Hou

http://www.w3.org/2001/XMLSchema#string

Wei-Ling He

http://www.w3.org/2001/XMLSchema#string

Wu Song

http://www.w3.org/2001/XMLSchema#string

Yu-Huang Li

http://www.w3.org/2001/XMLSchema#string

Yu-Long He

http://www.w3.org/2001/XMLSchema#string

Zun-Fu Ke

http://www.w3.org/2001/XMLSchema#string

P2860

MSH3 mismatch repair protein regulates sensitivity to cytotoxic drugs and a histone deacetylase inhibitor in human colon carcinoma cells

PCI-24781, a Novel Hydroxamic Acid HDAC Inhibitor, Exerts Cytotoxicity and Histone Alterations via Caspase-8 and FADD in Leukemia Cells

Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1

DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells

PCI-24781 induces caspase and reactive oxygen species-dependent apoptosis through NF-kappaB mechanisms and is synergistic with bortezomib in lymphoma cells

HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination

Competing roles of DNA end resection and non-homologous end joining functions in the repair of replication-born double-strand breaks by sister-chromatid recombination.

RAGE mediates accelerated diabetic vein graft atherosclerosis induced by combined mechanical stress and AGEs via synergistic ERK activation

Characterisation of the promoter region of the human DNA-repair gene Rad51

Anticancer activities of histone deacetylase inhibitors

P304

10094-10107

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V20.I29.10094

http://www.w3.org/2001/XMLSchema#string

P407

P433

29

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264628744

http://www.w3.org/2001/XMLSchema#string

P698

25110436

http://www.w3.org/2001/XMLSchema#string

P932

4123338

http://www.w3.org/2001/XMLSchema#string